Tech Company Financing Transactions
Shasqi Funding Round
Shasqi, operating out of San Francisco, secured $10 million in investment from Y Combinator.
Transaction Overview
Company Name
Announced On
11/1/2019
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Y Combinator (Uri Lopatin)
Proceeds Purpose
The proceeds of the financing are being used to complete GMP manufacturing for the company's lead drug candidate and to support a Phase 1 human trial, expected to commence in Q2 2020.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
665 3rd St. 250
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Undisclosed
Website
Email Address
Overview
Shasqi, Inc., founded in 2018, is a privately held company focused on developing cancer treatments using bioorthogonal click chemistry for localized drug delivery. Shasqi's treatments employ activating agents in an injected biomaterial to concentrate and activate systemic prodrug versions of cancer drugs directly at the tumor site.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
José Oneto
Browse more venture capital transactions:
Prev: 11/1/2019: dotData venture capital transaction
Next: 11/1/2019: Crunchbase venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs